Voyageur Pharmaceuticals (VYYRF) Stock Price, News & Analysis

Company Overview

Voyageur Pharmaceuticals Ltd. is a Canadian pharmaceutical company focused on developing and commercializing contrast media used in medical imaging. Its product portfolio is centered on barium sulfate and iodine-based contrast agents, which help healthcare professionals visualize structures within the body during diagnostic procedures such as X-rays, computed tomography scans and other imaging examinations.

The company’s activities include the development, regulatory advancement and potential commercialization of pharmaceutical-grade contrast media. Voyageur has also emphasized establishing supply and manufacturing capabilities for the raw materials used in these products, with the goal of supporting reliable access to contrast agents for healthcare markets.

Voyageur Pharmaceuticals is headquartered in Canada and has pursued opportunities to serve domestic and international medical-imaging markets. The company’s publicly available materials focus primarily on its contrast-media development programs; detailed information about its current leadership, commercial distribution footprint and marketed product availability may change as its programs advance.

Key Stats

• Today's Range: $0.09 to $0.09
• 50-Day Range: $0.08 to $1.00
• 52-Week Range: $0.00 to $1.03
• Volume: 16,010 shs
• Average Volume: 28,327 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:VYYRF
• CIK: N/A
• Web: voyageurpharmaceuticals.ca
• Phone: (587) 779-6166
• Fax: N/A
• Employees: 6
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A